Synta director reports purchase of company shares

By Lisa Kerner

Charlotte, N.C., June 20 - Keith R. Gollust, a Synta Pharmaceuticals Corp. director, bought 96,097 shares of the company's stock between May 16 and June 11.

The shares were priced from $6.94 to $7.17 each, according to a schedule 13D filed with the Securities and Exchange Commission.

Gollust beneficially owns 1,708,243 shares, or 5%, of the Lexington, Mass., biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.